ATE146970T1 - Behandlung von entzündungen - Google Patents

Behandlung von entzündungen

Info

Publication number
ATE146970T1
ATE146970T1 AT91920172T AT91920172T ATE146970T1 AT E146970 T1 ATE146970 T1 AT E146970T1 AT 91920172 T AT91920172 T AT 91920172T AT 91920172 T AT91920172 T AT 91920172T AT E146970 T1 ATE146970 T1 AT E146970T1
Authority
AT
Austria
Prior art keywords
treatment
inflammation
cells
mast
mediators
Prior art date
Application number
AT91920172T
Other languages
English (en)
Inventor
John Lezdey
Allan Wachter
Original Assignee
John Lezdey
Allan Wachter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27416749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE146970(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/683,620 external-priority patent/US5190917A/en
Application filed by John Lezdey, Allan Wachter filed Critical John Lezdey
Application granted granted Critical
Publication of ATE146970T1 publication Critical patent/ATE146970T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91920172T 1990-10-16 1991-09-26 Behandlung von entzündungen ATE146970T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59824190A 1990-10-16 1990-10-16
US64372791A 1991-01-18 1991-01-18
US07/683,620 US5190917A (en) 1986-12-24 1991-04-11 Treatment of psoriasis

Publications (1)

Publication Number Publication Date
ATE146970T1 true ATE146970T1 (de) 1997-01-15

Family

ID=27416749

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91920172T ATE146970T1 (de) 1990-10-16 1991-09-26 Behandlung von entzündungen

Country Status (10)

Country Link
EP (1) EP0512090B2 (de)
AT (1) ATE146970T1 (de)
AU (1) AU679165B2 (de)
CA (1) CA2091354C (de)
DE (1) DE69123960T2 (de)
DK (1) DK0512090T4 (de)
ES (1) ES2096665T3 (de)
GR (1) GR3022533T3 (de)
OA (1) OA09768A (de)
WO (1) WO1992006706A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4227762A1 (de) * 1992-08-24 1994-03-03 Behringwerke Ag Verwendung eines Kallikrein-Inhibitors zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie bestimmter Krankheiten
US5837699A (en) 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5939525A (en) * 1995-03-27 1999-08-17 Viron Therapeutics, Inc. Methods of treating inflammation and compositions therefor
US5614198A (en) * 1995-07-25 1997-03-25 The Trustees Of The University Of Pennsylvania Bowman-Birk Inhibitor compositions for treatment of inflammatory disease
DE19600480A1 (de) * 1996-01-09 1997-07-10 Beiersdorf Ag Verwendung von Serin-Proteinasen gegen Akne und entzündete Comedonen
US5780440A (en) * 1996-06-17 1998-07-14 Protease Sciences Inc. Treatment of pulmonary disease with protease inhibitors
EP0834556A1 (de) * 1996-09-25 1998-04-08 Academisch Ziekenhuis Leiden Verfahren zur Zellkultivierung
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
WO1999049887A1 (en) * 1998-04-01 1999-10-07 Biotech Australia Pty. Limited Use of protease inhibitors for treating skin wounds
EP1163900A1 (de) * 1998-11-05 2001-12-19 Protease Sciences, Incorporated Kosmetische Zubereitung human-typische Serin-Protease-Inhibitoren enthaltend
CA2383486A1 (en) * 1999-02-01 2000-08-03 Darren Lezdey Treatment of bladder and gastrointestinal mastocytosis
WO2000050057A1 (en) 1999-02-22 2000-08-31 Bernstein Eric F Compositions and methods for prevention of photoaging
JP4610832B2 (ja) 1999-10-26 2011-01-12 株式会社 ジャパン・ティッシュ・エンジニアリング 創収縮抑制薬剤
AU1123001A (en) 1999-10-27 2001-05-08 Alexandra Lucas Compositions and methods for preventing and treating transplant rejection
WO2001064031A2 (en) * 2000-03-01 2001-09-07 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Slpi knockout mice and methods for wound treatment
AU2001291579B2 (en) 2000-09-29 2006-08-31 Viron Therapeutics Inc. Use of serp- 1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
AU2002254999B2 (en) * 2001-04-30 2007-07-26 Bayer Innovation Gmbh Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
EP1390062A4 (de) * 2001-05-02 2005-09-14 Blood Res Center Modulatoren der elastase-inhibitor-sekretion
GB0125594D0 (en) * 2001-10-25 2001-12-19 Univ Sheffield Inhibitors for inactivating allergens
EP1415664A1 (de) * 2002-10-30 2004-05-06 Switch Biotech Aktiengesellschaft Verwendung von Alpha-1-antichymotrypsin in Kombination mit Alpha-1-antitrypsin zur Behandlung/Vorbeugung von schlecht heilenden arteriellen oder diabetischen Wunden
ATE439853T1 (de) * 2002-11-20 2009-09-15 Arriva Prometic Inc Zusammensetzung zur behandlung von ichthyosis unter verwendung von antitrypsin
EP3192872A1 (de) 2003-08-26 2017-07-19 The Regents of the University of Colorado, a body corporate Inhibitoren der serinproteaseaktivität und deren verwendung in verfahren und zusammensetzungen zur behandlung bakterieller infektionen
US7226995B2 (en) 2003-10-23 2007-06-05 Stc.Unm Use of C-reactive protein to treat immune complex-mediated renal disease
GB0411145D0 (en) * 2004-05-19 2004-06-23 Imp College Innovations Ltd Protease inhibitors and their therapeutic applications
WO2005115385A1 (en) * 2004-05-24 2005-12-08 Ab Science Use of c-kit inhibitors for treating acne
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
EP2069377A4 (de) * 2006-09-27 2009-11-11 Univ California Verfahren und zusammensetzungen zur behandlung von hautkrankheiten und hautfunktionsstörungen
WO2012029061A2 (en) 2010-08-31 2012-03-08 Uri Wormser POLYPEPTIDES DERIVED FROM α-1 ANTITRYPSIN AND METHODS OF USE THEREOF
US9518107B2 (en) 2010-08-31 2016-12-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Pharmaceutical compositions containing polypeptides derived from α-1 antitrypsin and methods of use thereof
US9938353B2 (en) 2011-06-24 2018-04-10 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
CA2896951A1 (en) 2012-01-10 2013-07-18 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
BR112014027333A2 (pt) * 2012-05-01 2017-07-18 Univ Duke composição, métodos de tratamento ou melhora, de prevenção, e, de diagnóstico de uma condição prejudicial que está associada com o teor elevado de sulfato de heparano em um indivíduo que foi o receptor de um órgão, tecido ou células transplantados
EP2956003A2 (de) 2013-02-13 2015-12-23 Laboratoire Français du Fractionnement et des Biotechnologies Proteine mit modifizierter glykosylierung und verfahren zur herstellung davon
US9801848B2 (en) * 2013-03-13 2017-10-31 The Regents Of The University Of California Prevention of rosacea inflammation
US20190187141A1 (en) * 2016-07-19 2019-06-20 Arete Discoveries, Inc. Biomarkers for Detection and Treatment of Mast Cell Activity-Associated Disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0304971B1 (de) † 1982-08-13 1998-02-04 ZymoGenetics, Inc. Verfahren zur Herstellung eines Polypeptids mit der Proteasehemmenden Aktivität von Säugetier-alpha-1-Antitrypsin
AU3145184A (en) * 1983-08-16 1985-02-21 Zymogenetics Inc. High expression of foreign genes in schizosaccharomyces pombe
US5008242A (en) * 1986-12-24 1991-04-16 John Lezdey Treatment of inflammation using 1-antichymotrypsin
US4916117A (en) * 1986-12-24 1990-04-10 John Lezdey Treatment of inflammation using alpha 1-antichymotrypsin
US5093316A (en) † 1986-12-24 1992-03-03 John Lezdey Treatment of inflammation
JP2656944B2 (ja) † 1987-04-30 1997-09-24 クーパー ラボラトリーズ タンパク質性治療剤のエアロゾール化

Also Published As

Publication number Publication date
DK0512090T4 (da) 2007-01-15
OA09768A (en) 1993-11-30
ES2096665T3 (es) 1997-03-16
DE69123960D1 (de) 1997-02-13
WO1992006706A1 (en) 1992-04-30
DK0512090T3 (da) 1997-06-16
EP0512090A4 (en) 1993-05-05
EP0512090B2 (de) 2006-11-22
AU8929091A (en) 1992-05-20
GR3022533T3 (en) 1997-05-31
AU679165B2 (en) 1997-06-26
EP0512090A1 (de) 1992-11-11
CA2091354C (en) 2005-04-12
EP0512090B1 (de) 1997-01-02
DE69123960T2 (de) 1997-05-07
CA2091354A1 (en) 1992-04-17

Similar Documents

Publication Publication Date Title
DE69123960D1 (de) Behandlung von entzündungen
EA200101166A1 (ru) Ингибиторы металлопротеаз
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
DK0380367T3 (da) Præparater og fremgangsmåde til sygdomsbehandling
ATE207355T1 (de) Behandlung von hyperproliferativen gefässerkrankungen
DK0432117T3 (da) Farmaceutisk præparat til behandling af inflammation
PT92821A (pt) Processo para a preparacao composicoes farmaceuticas para o combate de doencas do tipo psoriase, bem como doencas inflamatorias, incorporando azelastina como substancia activa
DE68902798D1 (de) Verwendung von polymeren bei einer behandlung.
ES2058125T3 (es) Derivados de piperidina para el tratamiento del dolor.
ES2114117T3 (es) Acidos fenilalcan(en)oicos con actividad antagonista del leucotrieno b4.
DE68903092D1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
DE69125855D1 (de) Therapeutisch wirksame, örtliche anwendung von st1435
ES2032922T3 (es) Empleo de los paf-aceter antagonicos para la fabricacion de un medicamento y procedimiento para determinar la eficacia de los mismos.
ATE126061T1 (de) Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum.
DE69108748D1 (de) Antithrombin-Lösung und ihre Verwendung.
ES2166838T3 (es) 6-(triazolil(3-(trifluorometil)fenil)metil)-2-quinolinonas y -quinolinationas.
ES252138Y (es) Zapato ortopedico perfeccionado con punta automaticamente elevable al levantar el pie
SE8902607L (sv) Oxaza heterocykler och pharmaceutiska kompositioner innehaallande densamma
ITMI920979A1 (it) N-acil derivati di aminoalcooli come agenti terapeutici attivi sull'edema neurogenico endoneurale a livello del nervo periferico.
ATE120447T1 (de) Polyamin-derivate als antineoplastische mittel.
ES2036533T3 (es) Derivados de 1,6-naftiridina, procedimientos para su obtencion y de medicamentos que los contienen para el tratamiento de enfermedades de los vasos sanguineos.
ES517341A0 (es) Prensa hidraulica embaladora automatica y autodesinfectable para la eliminacion y el tratamiento en condiciones higienicas adecuadas de los residuos clinicos y hospitalarios infectados.
MX9304878A (es) Uso de un azaspirano substituido en la fabricacion de un medicamento para utilizarse en el tratamiento de psoriasis.
IT8024862A0 (it) L'applicazione in terapeutica come agenti analgesici dei derivati del 4,5,6,7-tetraidroisossazolo (5,4-c)piridin-3-ol
ES2063950T3 (es) Una composicion terapeutica utilizada como solucion de irrigacion intraocular.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties